Miguel Tovar Novartis' migraine drug gets EMA approval pharmatimes.com Aimovig becomes Europe’s first treatment specifically designed to prevent migraine
Miguel Tovar Pfizer CEO on what happened after Trump tweeted CNBC - Meg Tirrell Before he even spoke to the president, Pfizer CEO Ian Read said he knew the best move was to defer the drug giant's early July price increases; a …
Miguel Tovar Kyoto team pits iPS cells against Parkinson's disease japantimes.co.jp - No Author A Kyoto University research team said Monday it will begin a clinical test this week using induced pluripotent stem cells to treat Parkinson’s …
Miguel Tovar Highly Anticipated Data On Would-Be Alzheimer's Drug Raises Hope And Questions Forbes - Ellie KincaidHow does Biogen Chief Medical Officer Al Sandrock feel after the curtain was lifted on clinical trial data of the experimental Alzheimer’s drug his company is developing with Japanese drugmaker Eisai?
Miguel Tovar GSK bets $300 million on genetics as CEO plays down break-up talk Reuters - Ben HirschlerLONDON (Reuters) - GlaxoSmithKline aims to turbo-charge its drug discovery engine with a big bet on genetics as its CEO on Wednesday played down the idea of hiving off consumer healthcare, which is a of
